The CARDIO-TTRansform Scintigraphy Sub-study

The CARDIO-TTRansform Scintigraphy Sub-study

Conditions: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Interventions: Diagnostic Test: Scintigraphy scan
Sponsors: Ionis Pharmaceuticals, Inc.; AstraZeneca
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 11, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments